课题基金 / 基金详情

An investigation into ACE2 as a molecular and genetic link to human coronary artery disease

An investigation into ACE2 as a molecular and genetic link to human coronary artery disease
ACE2 与人类冠状动脉疾病的分子和遗传联系的研究
批准号:
nhmrc : 1132717
负责人:
金额:
$6.14万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Postgraduate Scholarships
财政年份:
2017
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2017-01-01 至 2019-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
冠状动脉疾病(CAD)是导致死亡的主要原因,但仍被低估,因此需要更好的测试。我们计划对患有和不患有冠心病的患者进行一次简单的新的血液测试。我们的理论是,只有冠心病患者的血液水平才会显著升高。如果我们的理论得到证实,那么这项测试可能会被用来更好地预测那些患有CAD的人,甚至在他们出现症状之前。这将使及早提供预防策略,可能会减少冠心病的并发症。
英文摘要
Coronary artery disease (CAD) is a leading cause of death but remains underdiagnosed so better tests are needed. We plan to perform a simple, new blood test in those with and without CAD. Our theory is that blood levels will be significantly increased only in those with CAD. If our theory is confirmed, this test may then be used to better predict those with CAD even before they develop symptoms. It will allow provision of early prevention strategies which will likely reduce complications of CAD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金